Related Experiment Video
Updated: May 16, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of
Yan Tao1, Yin-Jie Gu, Zhi-Hong Cao
1School of Medical Science and Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013;
Abstract:
In our previous study, we demonstrated that type II cGMP-dependent protein kinase (PKG II) was expressed at lower levels in different human cancer cell lines and that exogenous PKG II inhibited epidermal growth factor (EGF)-induced MAPK/ERK signaling. In order to investigate its functions further in this signaling pathway, it is necessary to elucidate whether endogenous PKG has the same effect or not. This study aimed to investigate the possible inhibitory effect of endogenous PKG activity on EGF-induced MAPK/ERK signal transduction in human lung cancer cells and its mechanism. Human small cell lung carcinoma cells (SCLCs) were treated with the PKG-selective cGMP analog 8-pCPT-cGMP to activate endogenous PKG, EGF and cGMP followed by EGF, respectively. The results showed that increased endogenous PKG activity inhibited the EGF-induced phosphorylation of the epidermal growth factor receptor (EGFR) and the binding between Sos1 and Grb2. In addition, EGF-triggered Ras activation was reversed by increased endogenous PKG activity. While the EGF-induced phosphorylation of MEK and ERK were inhibited by increased endogenous PKG activity, there was a significant increase of phosphorylated vasodilator-stimulated phosphoprotein (p-VASP) at Ser239. Furthermore, we investigated whether endogenous PKG exerted its effects on EGF-induced MAPK/ERK signaling through phosphorylation of VASP at Ser239. Downregulation of the levels of p-VASP Ser239 by point mutation blocked the effects of endogenous PKG on EGF-induced MAPK/ERK signal transduction. The data shown here suggest that endogenous PKG reverses the EGF-induced MAPK/ERK signaling pathway by phosphorylating VASP at Ser239.
Insights
Endogenous protein kinase G (PKG) activity inhibits epidermal growth factor (EGF)-induced MAPK/ERK signaling in lung cancer cells by phosphorylating VASP. This finding reveals a novel mechanism for controlling cancer cell signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Type II cGMP-dependent protein kinase (PKG II) is downregulated in human cancer cells.
- Exogenous PKG II inhibits epidermal growth factor (EGF)-induced MAPK/ERK signaling.
Purpose of the Study:
- To investigate the inhibitory effect of endogenous PKG activity on EGF-induced MAPK/ERK signal transduction in human lung cancer cells.
- To elucidate the underlying mechanism of this inhibition.
Main Methods:
- Human small cell lung carcinoma cells (SCLCs) were treated with a PKG activator (8-pCPT-cGMP) and/or EGF.
- Key signaling proteins including EGFR, Sos1, Grb2, Ras, MEK, ERK, and VASP were analyzed for phosphorylation and binding interactions.
- VASP phosphorylation site (Ser239) was mutated to block PKG's effect.
Main Results:
- Increased endogenous PKG activity inhibited EGF-induced phosphorylation of EGFR, Sos1-Grb2 binding, and Ras activation.
- EGF-induced MEK and ERK phosphorylation were suppressed by endogenous PKG.
- PKG activation led to increased VASP phosphorylation at Ser239.
- Blocking VASP phosphorylation at Ser239 abolished PKG's inhibitory effects on the MAPK/ERK pathway.
Conclusions:
- Endogenous PKG activity reverses EGF-induced MAPK/ERK signaling in lung cancer cells.
- This reversal is mediated through the phosphorylation of VASP at Ser239.
- PKG acts as a negative regulator of the EGF-driven MAPK/ERK pathway in this context.
Related Concept Videos
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...

